project id: TCGA-UCEC; case submitter id: TCGA-A5-A2K3; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.6; age at index: 68; days to birth: -24907; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 24907; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2012.0; figo stage: Stage IA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1431; days to sample procurement: 0; initial weight: 120.0; portion submitter id: TCGA-A5-A2K3-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 85.0;